We are live on ! Find out more
CDTX

Cidara Therapeutics

Delisted

CDTX was delisted on the 6th of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$11M
IVM
2
InterWest Venture Management
California
$10.2M
FM
3
Frazier Management
Washington
$9.84M
BB
4
BB Biotech
Switzerland
$8.27M +$406K +2,938 +6%
AC
5
Aisling Capital
New York
$7.66M
BC
6
Broadfin Capital
New York
$6.12M +$1.75M +12,670 +45%
Millennium Management
7
Millennium Management
New York
$4.42M +$2.58M +18,698 +174%
OFM
8
Omega Fund Management
Massachusetts
$3.34M
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.25M -$295K -2,132 -12%
RSCM
10
Rock Springs Capital Management
Maryland
$2.25M
TCM
11
Tekla Capital Management
Massachusetts
$2.15M
EAM
12
Eventide Asset Management
Massachusetts
$1.98M
DCM
13
DAFNA Capital Management
California
$1.56M
PVI
14
Pura Vida Investments
New York
$1.13M +$1.04M +7,500 New
GC
15
Guggenheim Capital
Illinois
$1.06M +$982K +7,103 New
Renaissance Technologies
16
Renaissance Technologies
New York
$1.02M +$691K +5,000 +282%
SM
17
Sabby Management
Florida
$938K -$364K -2,630 -30%
WFI
18
West Family Investments
California
$750K
Alyeska Investment Group
19
Alyeska Investment Group
Illinois
$719K -$20.2K -146 -3%
Goldman Sachs
20
Goldman Sachs
New York
$650K +$599K +4,332 New
Jacobs Levy Equity Management
21
Jacobs Levy Equity Management
New Jersey
$481K +$443K +3,208 New
PA
22
Perceptive Advisors
New York
$465K -$5.28M -38,212 -92%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$359K -$149K -1,077 -31%
BlackRock
24
BlackRock
New York
$356K -$3.68M -26,620 -92%
PP
25
Paloma Partners
Connecticut
$353K +$325K +2,350 New